Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2005
05/19/2005WO2005044301A2 Use of specific histones for the treatment of parasitic diseases
05/19/2005WO2005044300A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica
05/19/2005WO2005044299A1 Cytoprotective effects of ethyl pyruvate
05/19/2005WO2005044298A1 Compositions and methods of treatment
05/19/2005WO2005044294A2 Method of therapy for cancers expressing the cd40 antigen
05/19/2005WO2005044293A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same
05/19/2005WO2005044200A2 Methods and compositions for treating mcp-1 related pathologies
05/19/2005WO2005044188A2 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent
05/19/2005WO2005044012A2 Method for the decontamination of biological tissue
05/19/2005WO2005021713A8 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
05/19/2005WO2005017093A8 Polypeptides of streptococcus pyogenes
05/19/2005WO2005016263A3 Compositions and methods for treating hyperimmune response in the eye
05/19/2005WO2005016111A9 Antibodies directed to parathyroid hormone (pth) and uses thereof
05/19/2005WO2005011732A3 Rabbit bacterium and uses thereof
05/19/2005WO2005011614A8 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
05/19/2005WO2004111075A8 Alternative reading frame polypeptides for treatment
05/19/2005WO2004110367A3 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
05/19/2005WO2004100659A3 Dinoflagellate karlotoxins, methods of isolation and uses thereof
05/19/2005WO2004098636A3 Vaccinating against infectious diseases using proteosomes
05/19/2005WO2004098526A3 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
05/19/2005WO2004076639B1 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
05/19/2005WO2004076634A3 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
05/19/2005WO2004045495A3 Interacting site for gp41 on gp120 of hiv-1
05/19/2005WO2004039244A3 Methods and kits for diagnosing tumorigenicity
05/19/2005WO2004022762A9 Orthopoxvirus vectors, genes and products thereof
05/19/2005WO2003092592A3 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
05/19/2005WO2003049678A3 Mitotic kinesin inhibitors
05/19/2005US20050108792 Plastid transformation vector comprising anthrax protective antigen for use in generation of edible vaccines for conferring immunity to mammal against bacillus anthracis
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107587 Hdv nucleic acid molecules fragments and applications thereof
05/19/2005US20050107465 Composition for treating inflammatory bowel disease
05/19/2005US20050107404 Mitotic kinesin inhibitors
05/19/2005US20050107322 Compositions for inducing immune responses
05/19/2005US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease
05/19/2005US20050107309 Lowering elevated post-prandial blood glucose levels by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity; insulinotropic effects are enhanced
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107277 Polyalkylene polymer compounds and uses thereof
05/19/2005US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
05/19/2005US20050106728 Using gamma irradiation to decontaminate biofluids and materials
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106648 Immmunoglobulin specific to staphylococcal surface protein for use in diagnosis and prevention of bacterial infection; vaccine development; immunotherapy
05/19/2005US20050106647 Antibodies with increased affinities for anthrax antigens
05/19/2005US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents
05/19/2005US20050106633 Methods for diabetes susceptibility assessment in asymptomatic patients
05/19/2005US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106597 Nucleotide sequences coding bacterial polypeptides for use in generating antibodies to prevent and treat staphylococcal infection
05/19/2005US20050106586 Detection of neurodegenerative diseases
05/19/2005US20050106565 Hybrid nucleic acids, ant antibodies thereof; insecticide
05/19/2005US20050106185 Vaccines comprising acapsular P. multocida hyaE deletion mutants
05/19/2005US20050106184 Genetic engineered mutants lipid
05/19/2005US20050106183 Method of treating pain
05/19/2005US20050106181 Capsular polysaccharide solubilisation and combination vaccines
05/19/2005US20050106180 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
05/19/2005US20050106179 Isolated complexes of endotoxin and MD-2
05/19/2005US20050106178 Adjuvanted influenza vaccine
05/19/2005US20050106177 Stabilized by introducing trimeric motifs, preferably GCN4 coiled coil or fibritin trimeric domain at certain sites, for example in gp41 ectodomain; trimers or DNA molecules encoding such trimers can be used to generate immunogenic reactions
05/19/2005US20050106176 Vector reproduction using Dna polymerase; linking to chromosome; encoded as foreign gene; genetic engineering
05/19/2005US20050106175 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages
05/19/2005US20050106164 Recombinant expression of heterologous nucleic acids in protozoa
05/19/2005US20050106163 Bovine immunization of new born calf against enteric disease
05/19/2005US20050106162 Immunisation against chlamydia trachomatis
05/19/2005US20050106161 Vaccine ; human leukemia, lymphoma virus
05/19/2005US20050106160 Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens
05/19/2005US20050106158 Antigen mimotopes and vaccine against cancers
05/19/2005US20050106157 Immunogenic formulations comprising oil bodies
05/19/2005US20050106156 Allergy desensitivation to myelin and melatonin
05/19/2005US20050106155 Solidified tissue immuoadjuvant
05/19/2005US20050106154 GASP1: a follistatin domain containing protein
05/19/2005US20050106153 mixture of immunoadjuvant in neoplasm; applying stresses to destroy neoplastic tissue; administering immunomoderator ; in situ generation of autologous vaccine
05/19/2005US20050106151 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax
05/19/2005US20050106150 Restoring sensitivity to drug resistant tumor cells
05/19/2005US20050106149 Antibodies abolish prion propagation and remote clearance of infectivity
05/19/2005US20050106148 Method of treating blood disorders
05/19/2005US20050106147 Method of promoting graft survival with anti-tissue factor antibodies
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106143 Collapsin response mediator protein; measurement of gene expression
05/19/2005US20050106142 Rheumatic arthritis; hepatitis c virus; autoimmune diseases ; nterfering with forming or binding of such; autoantigen
05/19/2005US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof
05/19/2005US20050106139 Humanized tissue factor antibodies
05/19/2005US20050106137 Chimeric peptide immunogens
05/19/2005US20050106136 Controlling capilalries, blood vessels in eye; vision defects
05/19/2005US20050106130 Transgenic human cells expressing antiproliferative agents; gene therapy; anticancer agents; tissue engineering; generating immunology response
05/19/2005US20050106129 Method of obtaining immune cells from an animal
05/19/2005US20050106123 Using primers; heterogeneity genetic engineered adenovirus or poxviruse vectors
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/19/2005US20050106107 TRansdermal drug delivery device; topical applying mycobacterial antigen; diagnosis of tuberculosis
05/19/2005US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/19/2005US20050103712 Immunoadsorbents are monoclonal or polyclonal antibodies affixed with solid support capable of a absorbing toxin released from infecting bacteria allowing removal of the toxin
05/19/2005DE10348319A1 Bindemoleküle für die Extra-Domäne B von Fibronectin zur Detektion von atherosklerotischen Plaques Binding molecules for the extra-domain B of fibronectin for detection of atherosclerotic plaques
05/19/2005CA2545166A1 Humanized anti-cd47 antibody
05/19/2005CA2544951A1 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
05/19/2005CA2544949A1 Antagonist anti-cd40 monoclonal antibodies and methods for their use
05/19/2005CA2544948A1 Methods of therapy for cancers expressing the cd40 antigen
05/19/2005CA2544924A1 Methods and compositions for treating mcp-1 related pathologies
05/19/2005CA2544865A1 Cd20 antibodies with increased fc receptor binding affinity and effector function
1 ... 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 ... 1823